Authors


Daniel F Kiernan, MD, FACS

Latest:

Impressions and Takeaways From Patient Case #2

Daniel F Kiernan, MD, FACS, discusses the use of anti-inflammatory treatment when experiencing sub-optimal response with anti-VEGF therapy in DME.


Sonya Besagar, MD

Latest:

Diagnostic Maze: Navigating the complexity of isolated optic disc edema in syphilitic uveitis

With cases of syphilitic uveitis on the rise, recognizing its varied presentations—including optic disc edema, which may appear without other significant eye inflammation—is increasingly important for timely diagnosis and treatment.


Sharon Fekrat, MD, FACS, FASRS

Latest:

Q&A: Sharon Fekrat, MD, FACS, FASRS, on the value of scientific meetings and collaboration

Sharon Fekrat, MD, FACS, FASRS, highlights the critical importance of networking and collaboration in the medical field, particularly in ophthalmology.


Jason Smith, DNP, CRNA

Latest:

Study finds sublingual troche, IV sedation are equivalent for cataract surgery

The method by which sedation is applied to keep patients relaxed and comfortable throughout cataract surgery can be tailored similar to that of anesthesia — surgical anesthesia is not a one size fits all endeavor.


Brian Woods, MBBCh

Latest:

Artificial intelligence enhances detection of neuro-ophthalmic disorders

Deep learning discerns IIH, NAION, and normal eyes using single fundus image.


Ashley A. Ooms, MD

Latest:

DMEI resident Ashley Ooms, MD, explores gray area strabismus surgery complications in AUPO poster

Ooms' poster at the Association of University Professors of Ophthalmology annual meeting highlighted a study on gray area complications in strabismus surgery, showing that trainees are more likely than attendings to disclose these complications despite having similar baseline anxiety levels. Ooms is a PGY-4 ophthalmology resident at the Dean McGee Eye Institute.


Victor A. Augustin, MD

Latest:

Artificial DMEK could help tackle endothelial donor tissue shortage

New acrylic implant provides option for patients with endothelial dysfunction.


Marc R. Bloomenstein, OD, FAAO

Latest:

Topical presbyopic correction: a postoperative problem solver

Presbyopia-correcting drops represent a whole new product category—one with a lot of upsides for clinicians who want to help their patients see well at all distances.


Vasant Raman, MS, FRCS

Latest:

Should nonclinicians inject dexamethasone implants?

Studies on nurse-led services find a low level of complications among patients.


Michael Greenwood, MD

Latest:

Advantages of incorporating ECP into the surgeon’s armamentarium

Short learning curve, significant clinical advantages make this a comfortable addition.


Saif Alryalat, MD

Latest:

What ophthalmologists need to know about neuromyelitis optica spectrum disorder

Early diagnosis of NMOSD is key to preventing disability, improving survival.


Phillip H. Phan, PhD

Latest:

Clearing hurdles to large scale telemedicine adoption

During the COVID-19 pandemic, it is important to develop technologies to keep patients and staff safe, while treating the diseases of the eye


Steven Ferrucci, OD, FAAO

Latest:

ACHIEVING IMPROVED OUTCOMES THROUGH PARTNERSHIPS BETWEEN OPTOMETRISTS AND RETINA SPECIALISTS

Considerations in the treatment of diabetic retinopathy and diabetic macular edema.


Bryce W. Polascik, BS

Latest:

Welcome to the metaverse: Technology allows ophthalmologists to mingle with colleagues worldwide

Answers to common questions that can help kick-start the journey into the metaverse to learn from the many virtual educational meetings and conference opportunities while mingling with colleagues worldwide.


Anisha Kasi

Latest:

ARVO 2025: Inflammatory eye disorders in hidradenitis suppurativa patients

At ARVO 2025, in Salt Lake City, Utah, Anisha Kasi talked about her presentation on how her team used the TriNetX database, a large database of over 150 million patients worldwide, to validate the connection between hidradenitis suppurativa and inflammatory eye conditions.


Ellen Koo, MD

Latest:

ARVO 2025: First in-human clinical trials results from magnetic cell therapy

Ellen Koo, MD, presented data from first in-human clinical trials, looking at the results from magnetic cell therapy and reports on the efficacy and safety in the patients.


Edward Yung, MD

Latest:

Long-Term Outcomes After Nonimplant MIGS Procedure

A panelist discusses how nonimplant MIGS, such as viscocanaloplasty and viscoelastic delivery devices, offer long-term IOP reduction and medication savings, emphasizing their benefits for early intervention and improved postoperative quality of life, while noting limitations for more advanced glaucoma conditions.


Adrienne Graves, PhD

Latest:

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

The 14th annual Glaucoma 360 conference, co-founded by Adrienne Graves, PhD, and Andrew Iwach, MD, and hosted by Glaucoma Research Foundation, will be held from February 6-8, 2025, at the Westin St. Francis in San Francisco, California. The event will focus on the latest advancements in glaucoma care and encourage innovation and collaboration.


Robert Fintelmann, MD, FACS

Latest:

Monitor keratoconus progression after cross-linking treatment

Contemporary scleral lenses work so well that stable vision in them cannot necessarily be taken as a sign that KC progression has stopped. Determination of KC progression requires advanced imaging.


Amar P. Shah, MD

Latest:

ASCRS 2025: Amar Shah, MD, on why hyperosmolar tear film before and after cataract surgery matters

A significant proportion of cataract surgery patients exhibit hyperosmolar tear film both before and 1 month after surgery, underscoring preoperative screening and postoperative management to optimize visual outcomes.


Penny Asbell, MD, MBA, FACS, FARVO

Latest:

Cyclosporine drop for treating dry eye offers new advantages

Delivered in a water-free solution, Vevye’s new formulation offers a high concentration of cyclosporine that works rapidly, has no preservatives, and rarely causes irritation


Shivani Majmudar

Latest:

One shingle at a time: Starting a solo practice

Sometimes, the best job for you is the one you create.


M. Roy Wilson, MD, MS

Latest:

Shaffer-Hetherington-Hoskins Lecture at the 2025 Glaucoma 360 meeting

M. Roy Wilson, presented the Shaffer-Hetherington-Hoskins Lecture at the Glaucoma 360 meeting held in San Francisco, California. This lecture was entitled, "Rethinking Race as a Risk Factor for Glaucoma: What Really Matters?"


Delu Song, MD, PhD, MTR

Latest:

IVIg, ICVM may help patients with small fiber neuropathy, neuropathic corneal pain

NCP should be considered for patients with discomfort, irritation, dryness, grittiness.


Robert Maloney, MD, MA

Latest:

Robert Maloney, MD, announces retirement from clinical practice

Following his keynote address at Controversies in Modern Eye Care, Dr. Maloney said he will be leaving his surgical practice and returning to research.




Paola Rivera Morales, MD

Latest:

Tuning out anxiety: the role of music in cataract surgery

From easing fears to improving mood, a recent study explores how music transforms the surgical experience for both patients and health care teams.


Cristina Cosula, MD

Latest:

Study examines efficiency of physiotherapy in treating, preventing uncomplicated acquired myopia

Research explores innovative physiotherapeutic approaches to managing myopia progression, showing promising results in slowing its advancement over two years.


David A. Eichenbaum, MD

Latest:

(Part 2) From ophthalmology’s lockdown to lasting change: The pandemic habits that stuck

From revised patient flow to smarter tech adoption, ophthalmologists share which changes from 2020 have become cornerstones of modern care—and how they’re preparing for the next big disruption

© 2025 MJH Life Sciences

All rights reserved.